Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L. Levine, D. Gary Gilliland, Peter Marynen et al.|Cancer Cell|2005Cited by 3k
The genetic basis of early T-cell precursor acute lymphoblastic leukaemiaJinghui Zhang, Meenakshi Devidas, Li Ding et al.|Nature|2012Cited by 1.6k
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signalingPatricia Altea‐Manzano, Sarah‐Maria Fendt, Ginevra Doglioni et al.|Nature Cancer|2023Cited by 140
The ability of sorafenib to inhibit oncogenic PDGFR and FLT3 mutants and overcome resistance to other small molecule inhibitorsEls Lierman, Jan Cools|Haematologica|2007Cited by 93
Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemiaMichaël Broux, Jan Cools|Blood|2019Cited by 63